Top

Digestive Diseases and Sciences

Published in:

21-07-2023 | Original Article

WallFlex^® and Evolution^® Duodenal Stents Have Similar Efficacy but Different Safety for Malignant Gastric Outlet Obstruction

Authors: Antoine Meyer, Antoine Martin, Christophe Bellanger, Franck Carbonnel, Isabelle Boytchev

Published in: Digestive Diseases and Sciences | Issue 9/2023

Abstract

Background

The WallFlex^® and Evolution^® stents are the most widely used duodenal stents, but no study has compared them.

Aims

We aimed to compare the efficacy and safety of WallFlex^® and Evolution^® stents for malignant gastric outlet obstruction.

Methods

We included all consecutive patients who were treated for malignant gastric outlet obstruction with WallFlex^® or Evolution^® self-expandable metal uncovered duodenal stents between 2013 and 2020. Multivariable Cox models were performed to assess duodenal stent failure, as defined by gastric outlet obstruction necessitating another duodenal stent.

Results

We included 129 patients: 74 received a WallFlex^® stent and 55 received an Evolution^® stent. The non-failure rate was of 68% (95%CI 55–84) and 65% (95%CI 50–84) at 6 months and of 48% (95%CI 32–73) and 45% (95%CI 27–74) at 1 year, with the WallFlex^® and Evolution^® stents, respectively. The median time to duodenal stent failure was 10.5 months in the WallFlex^® group and 9.3 months in the Evolution^® group. The type of duodenal stent was not associated with duodenal stent failure (p logrank = 0.43, adjusted hazard ratio 1.55; 95%CI 0.77–3.14). The overall survival was similar between the two groups (p logrank = 0.92). Three patients had complications due to Evolution^® stents; it consisted in dismantled stents that led to hemorrhage in one patient.

Conclusions

WallFlex^® and Evolution^® duodenal stents had similar efficacy for malignant gastric outlet obstruction. There were more adverse events with Evolution^® stents.

Available only for authorised users

van Halsema EE. Self-expandable metal stents for malignant gastric outlet obstruction: A pooled analysis of prospective literature. World J Gastroenterol 2015;21:12468. https://doi.org/10.3748/wjg.v21.i43.12468.CrossRefPubMedPubMedCentral

Dormann A, Meisner S, Verin N, Wenk Lang A. Self-Expanding Metal Stents for Gastroduodenal Malignancies: Systematic Review of their Clinical Effectiveness. Endoscopy 2004;36:543–550. https://doi.org/10.1055/s-2004-814434.CrossRefPubMed

Troncone E, Fugazza A, Cappello A, Blanco GDV, Monteleone G, Repici A et al. Malignant gastric outlet obstruction: Which is the best therapeutic option? World J Gastroenterol 2020;26:1847–1860. https://doi.org/10.3748/wjg.v26.i16.1847.CrossRefPubMed

Uemura S, Iwashita T, Iwata K, Mukai T, Osada S, Sekino T et al. Endoscopic duodenal stent versus surgical gastrojejunostomy for gastric outlet obstruction in patients with advanced pancreatic cancer. Pancreatology 2018;18:601–607. https://doi.org/10.1016/j.pan.2018.04.015.CrossRefPubMed

Business Wire. Top 6 Vendors in the Enteral Stents Market From 2017 to 2021 n.d. https://www.businesswire.com/news/home/20171011005876/en/Top-6-Vendors-in-the-Enteral-Stents-Market-From-2017-to-2021-Technavio (accessed May 17, 2021).

R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2013. http://www.R-project.org/.

Yamao K, Kitano M, Kayahara T, Ishida E, Yamamoto H, Minaga K et al. Factors predicting through-the-scope gastroduodenal stenting outcomes in patients with gastric outlet obstruction: a large multicenter retrospective study in West Japan. Gastrointest Endosc 2016;84:757-763.e6. https://doi.org/10.1016/j.gie.2016.03.1498.CrossRefPubMed

Kim JH, Song H-Y, Shin JH, Choi E, Kim TW, Jung H-Y et al. Metallic stent placement in the palliative treatment of malignant gastroduodenal obstructions: prospective evaluation of results and factors influencing outcome in 213 patients. Gastrointest Endosc 2007;66:256–264. https://doi.org/10.1016/j.gie.2006.12.017.CrossRef

van Wanrooij RLJ, Vanella G, Bronswijk M, de Gooyer P, Laleman W, van Malenstein H et al. Endoscopic ultrasound-guided gastroenterostomy versus duodenal stenting for malignant gastric outlet obstruction: an international, multicenter, propensity score-matched comparison. Endoscopy 2022;54:1023–1031. https://doi.org/10.1055/a-1782-7568.CrossRefPubMed

10.

Ge PS, Young JY, Dong W, Thompson CC. EUS-guided gastroenterostomy versus enteral stent placement for palliation of malignant gastric outlet obstruction. Surg Endosc 2019;33:3404–3411. https://doi.org/10.1007/s00464-018-06636-3.CrossRefPubMedCentral

11.

Kim JW, Jeong JB, Lee KL, Kim D. Comparison between uncovered and covered self-expandable metal stent placement in malignant duodenal obstruction. World J Gastroenterol 2015;21:1580. https://doi.org/10.3748/wjg.v21.i5.1580.CrossRefPubMedPubMedCentral

12.

Woo SM, Kim DH, Lee WJ, Park KW, Park S-J, Han S-S et al. Comparison of uncovered and covered stents for the treatment of malignant duodenal obstruction caused by pancreaticobiliary cancer. Surg Endosc 2013;27:2031–2039. https://doi.org/10.1007/s00464-012-2705-6.CrossRefPubMed

13.

Pan Y, Pan J, Guo L, Qiu M, Zhang J. Covered versus uncovered self-expandable metallic stents for palliation of malignant gastric outlet obstruction: a systematic review and meta-analysis. BMC Gastroenterol 2014;14:170. https://doi.org/10.1186/1471-230X-14-170.CrossRefPubMedPubMedCentral

14.

Lim SG, Kim JH, Lee KM, Shin SJ, Kim CG, Kim KH et al. Conformable covered versus uncovered self-expandable metallic stents for palliation of malignant gastroduodenal obstruction: A randomized prospective study. Dig Liver Dis 2014;46:603–608. https://doi.org/10.1016/j.dld.2014.02.024.CrossRefPubMed

15.

Bang S, Kim HJ, Park JY, Park YS, Kim MH, Park SW et al. Effectiveness of self-expanding metal stents for malignant antropyloric and duodenal obstruction with a comparison between covered and uncovered stents. Hepatogastroenterology 2008;55:2091–2095.PubMed

16.

Isayama H, Nakai Y, Toyokawa Y, Togawa O, Gon C, Ito Y et al. Measurement of radial and axial forces of biliary self-expandable metallic stents. Gastrointest Endosc 2009;70:37–44. https://doi.org/10.1016/j.gie.2008.09.032.CrossRefPubMed

17.

Hirdes M, Vleggaar F, De Beule M, Siersema P. In vitro evaluation of the radial and axial force of self-expanding esophageal stents. Endoscopy 2013;45:997–1005. https://doi.org/10.1055/s-0033-1344985.CrossRefPubMed

18.

Okuwaki K, Kida M, Yamauchi H, Imaizumi H, Miyawaza S, Iwai T et al. Randomized controlled exploratory study comparing the usefulness of two types of metallic stents with different axial forces for the management of duodenal obstruction caused by pancreatobiliary cancer. J Hepato-Biliary-Pancreat Sci 2016;23:289–297. https://doi.org/10.1002/jhbp.341.CrossRef

19.

Kato H, Kawamoto H, Matsumoto K, Moriyama I, Kamada H, Tsutsumi K et al. Outcome of self-expandable metallic stent deployment in patients with malignant gastroduodenal outlet obstruction and Niti-S and WallFlex comparison: a multicenter retrospective clinical study: Metallic stent for malignant GOO. J Dig Dis 2016;17:518–525. https://doi.org/10.1111/1751-2980.12377.CrossRefPubMed

20.

van den Berg M, Haijtink S, Fockens P, Vleggaar F, Dijkgraaf M, Siersema P et al. First data on the Evolution duodenal stent for palliation of malignant gastric outlet obstruction (DUOLUTION study): a prospective multicenter study. Endoscopy 2013;45:174–181. https://doi.org/10.1055/s-0032-1326077.CrossRefPubMed

21.

van Hooft JE, Uitdehaag MJ, Bruno MJ, Timmer R, Siersema PD, Dijkgraaf MGW et al. Efficacy and safety of the new WallFlex enteral stent in palliative treatment of malignant gastric outlet obstruction (DUOFLEX study): a prospective multicenter study. Gastrointest Endosc 2009;69:1059–1066. https://doi.org/10.1016/j.gie.2008.07.026.CrossRefPubMed

22.

Adler DG, Baron TH. Endoscopic Palliation of Malignant Gastric Outlet Obstruction Using Self-Expanding Metal Stents: Experience in 36 Patients. Am J Gastroenterol 2002;97:7. https://doi.org/10.1111/j.1572-0241.2002.05423.x.CrossRef

23.

Pais-Cunha I, Castro R, Libânio D, Pita I, Bastos RP, Silva R et al. Endoscopic stenting for palliation of intra-abdominal gastrointestinal malignant obstruction: predictive factors for clinical success. Eur J Gastroenterol Hepatol 2018;30:1033–1040. https://doi.org/10.1097/MEG.0000000000001178.CrossRefPubMed

24.

Sasaki T, Isayama H, Nakai Y, Togawa O, Kogure H, Kawakubo K et al. Predictive factors of solid food intake in patients with malignant gastric outlet obstruction receiving self-expandable metallic stents for palliation: PREDICTIVE FACTORS FOR MALIGNANT GOO. Dig Endosc 2012;24:226–230. https://doi.org/10.1111/j.1443-1661.2011.01208.x.CrossRefPubMed

Title: WallFlex® and Evolution® Duodenal Stents Have Similar Efficacy but Different Safety for Malignant Gastric Outlet Obstruction
Authors: Antoine Meyer
Antoine Martin
Christophe Bellanger
Franck Carbonnel
Isabelle Boytchev
Publication date: 21-07-2023
Publisher: Springer US
Published in: Digestive Diseases and Sciences / Issue 9/2023
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-023-08036-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Aims

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2023

Fibrosis-4 Index Score Predicts Concomitant Coronary Artery Diseases Across the Spectrum of Fatty Liver Disease

Nintedanib Alleviates Chronic Pancreatitis by Inhibiting the Activation of Pancreatic Stellate Cells via the JAK/STAT3 and ERK1/2 Pathways

Influence of Frailty in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography for Biliary Stone Disease: A Nationwide Study

Impact of Inflammatory Bowel Disease Subtypes on the Post-liver Transplant Outcomes of Patients with Primary Sclerosing Cholangitis

Liver, Heart, Death… Can This Sequence Be Broken?

Decreased Risk of Preeclampsia in Women with Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials